Find News

Filter articles

Applied Filters

Showing 81 to 90 of 225 results

Mylan enters MPP agreement over affordable hepatitis C generics


Mylan has entered into a sub-licensing agreement with the Medicines Patent Pool, a UN-backed public health organisation, to expand access to chronic hepatitis C medicines in developing countries.

Sun Pharma acquires Biosintez

India, Russia24-11-2016

India-based drugs company Sun Pharma has agreed to acquire Russia-based pharmaceutical business Biosintez.

Sanofi and Genzyme recover domain at WIPO


Pharmaceutical company Sanofi and its subsidiary Genzyme have recovered a domain name that infringed a trademark at the World Intellectual Property Organization’s Arbitration and Mediation Center.

GSK triumphs in trademark suit in India


Pharmaceutical company GSK has triumphed in a trademark infringement dispute in India.

Sun Pharma to acquire Ocular Technologies for $40m


India-based pharmaceutical company Sun Pharma has agreed to acquire Ocular Technologies for $40 million.

Astellas to acquire Ganymed for €422m

Germany, Japan31-10-2016

Japanese pharmaceutical company Astellas and German biopharmaceutical company Ganymed have entered into an agreement under which Astellas will acquire Ganymed for €422 million.

Sunovion Pharmaceuticals acquires Cynapsus for $653m

Canada, Japan, US26-10-2016

Japanese company Sumitomo Dainippon Pharma’s US subsidiary, Sunovion Pharmaceuticals, has completed the acquisition of Cynapsus Therapeutics.

Novartis wins growth hormone domain dispute


Healthcare company Novartis has won a domain name dispute at the World Intellectual Property Organization Arbitration and Mediation Center.

Sun Pharma collaborates with ICGEB to develop dengue vaccine


Indian pharmaceutical company Sun Pharma and the International Centre for Genetic Engineering and Biotechnology have entered into an exclusive collaboration to develop a novel dengue vaccine for India and global markets.

Janssen sells five drugs for $155m


India-based Piramal Enterprises has signed an agreement with Belgian pharmaceutical company Janssen under which Piramal will acquire five anaesthesia and pain management products for $155 million in cash.

Showing 81 to 90 of 225 results